Pre-formed donor specific antibodies > 3000 MFI managed at the time of transplantation predicts early antibody-mediated rejection after heart transplantation in a large cohort of patients - 25/12/18
pages | 2 |
Iconographies | 1 |
Vidéos | 0 |
Autres | 0 |
Résumé |
Background |
The presence of untreated pre-formed donor specific anti-HLA antibodies (DSA) increases the risk of early antibody-mediated rejections (AMR) after heart transplantation (HTx) but no robust data concerning the Mean Fluorescence Intensity (MFI, a semi-quantitative evaluation of the amount of DSA) threshold is available.
Purpose |
To analyse risk factors for early AMR after HTx and determine a threshold value of MFI in a large cohort of patients transplanted with pre-formed DSA managed with plasmapheresis and immunoglobulines at the time of transplantation.
Methods |
We performed a retrospective single-center observational study. We included all consecutive patients with (1) a first non-combined HTx between 2009 and 2015, (2) pre-formed DSA>1000 MFI (on historical or day 0 sera). The primary-endpoint was biopsy-proven AMR (pAMR1 to 3 according to ISHLT guidelines) at 1 year post-transplant (death-censored).
Results |
A total of 194 patients met the inclusion criteria, including 181 patients with at least 1 endomyocardial biopsy (EMB) during follow-up. Thirty-seven patients were diagnosed with at least 1 episode of biopsy-proven AMR at 1 year. MFI of immunodominant pre-formed DSA was the only independent risk factor for biopsy-proven AMR (HR=1.08 for 500-increment, 95% CI=1.03–1.12). Optimal cut-off value of MFI of immunodominant DSA determined through ROC-curve analysis was 2913 (sensitivity=0.46; specificity=0.81 for biopsy proven AMR, AUC=0.72, Figure 1).
Conclusion |
In a large cohort of patients transplanted with pre-formed DSA managed at the time of transplantation, MFI of immunodominant DSA was the only risk factor for early AMR. Optimal threshold to predict AMR was about 3000.
Le texte complet de cet article est disponible en PDF.Plan
Vol 11 - N° 1
P. 140-141 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?